AI as partner, competitor or crutch? Biologists weigh benefits and risks
In a recent STAT+ opinion, UC Davis cell biology professor Paul Knoepfler discusses how artificial intelligence is reshaping biomedical research.
He acknowledges AI's ability to accelerate experiments and data analysis, describing it as a useful partner for scientists at any stage of their career.
At the same time, Knoepfler warns that reliance on AI could diminish researchers' own problem solving skills and may lead to job reductions for scientists who depend heavily on the technology.
He suggests that the impact of AI will vary depending on a researcher's experience level, urging the community to balance enthusiasm with caution.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “Opinion: STAT+: Is AI more a partner, competitor, or crutch for biomedical scientists?”
read at STAT ↗
comments(0)
5-min edit window · permanent after that